|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Outsourcing Part 2: An Introduction to Drug Discovery Strategies – New Opportunities Lie In A Fully Integrated Global Outsourcing Strategy
Datamonitor, Aug 2006, Pages: 105
The pharma industry is facing a crisis over R&D productivity, as reflected by the low level of new drug approvals despite companies investing the highest ever amounts in R&D. As a result, companies are seeking novel ways to drive growth, with many opting to increase their reliance on third parties - through licensing, collaborative and outsourcing agreements - in an attempt to achieve this.
Scope of this title:
-Evaluation of the key benefits and risks associated with outsourcing drug discovery functions
-In-depth country profiles examining the suitability of key emerging countries for outsourcing drug discovery work, including China, India, and Russia
-Case study analysis evaluating how companies use drug discovery outsourcing in practice
-Key recommendations on how companies can optimize their drug discovery outsourcing strategy and realize the full value it offers
Highlights of this title:
The emergence of countries such as China and India as suitable destinations for drug discovery outsourcing is creating new opportunities for foreign pharma and biotech companies to achieve cost savings as well as increase their overall R&D productivity, but companies must still proceed cautiously, as there are particular risks in these countries.
With the increasing globalization of the drug discovery service market, pharma and biotech companies must look to fully integrate global outsourcing into their drug discovery strategy to be able to exploit the full spectrum of benefits that different countries offer with respect to drug discover services.
Companies need to ensure they are realizing the maximum value that outsourcing drug discovery functions offers. As a result companies need to ensure they are using outsourcing strategically where possible, creating a robust screening process for vendors as well as using an effective management and monitoring system for external alliances.
Reasons to order your copy:
-Identify the best way to tackle the common reasons why outsourcing agreements fail to live up to the customer’s expectations
-Assess the commercial implications of the increasing globalization of the outsourcing market for drug discovery services
-Understand how to optimize the use of outsourcing in your drug discovery strategies to capture the maximum benefit
Customers who bought this item also bought
Outsourcing Drug Discovery to China and India
Pharmaceutical Outsourcing in Drug Discovery and Development: Contract Research Opportunity in India
China Pharma Outsourcing Market By 2015
Drug Discovery Outsourcing Market in India and China
Comparison of Pharma Outsourcing between China and India
China Pharma Outsourcing Annual Review 2009
Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China
Addressing Pharma’s R&D Productivity Crisis: Technological and Strategic Initiatives to Improve Core Drug Discovery Capabilities
Targeting Kinases for Drug Discovery
Overview of the European Drug Discovery Market
Overcoming Challenges in Antibacterial Drug Discovery and Development
Top 100 Best Pharma Outsourcing Service Providers in China and India
|
|
|
|
